Subclinical Myocardial Dysfunction in Patients with Persistent Dyspnea One Year after COVID-19—Why Should Screening for Cardiovascular Diseases Be Performed? Reply to Vankrunkelsven, P. Tendentious Paper—Titles and Wrong Conclusions Lead to Fear in the Population and Medical Overconsumption. Comment on “Luchian et al. Subclinical Myocardial Dysfunction in Patients with Persistent Dyspnea One Year after COVID-19. Diagnostics 2022, 12, 57”

Detalles Bibliográficos
Autores principales: Luchian, Maria-Luiza, Motoc, Andreea, Lochy, Stijn, Magne, Julien, Belsack, Dries, De Mey, Johan, Roosens, Bram, Van den Bussche, Karen, Boeckstaens, Sven, Chameleva, Hadischat, Geers, Jolien, Houard, Laura, De Potter, Tom, Allard, Sabine, Weytjens, Caroline, Droogmans, Steven, Cosyns, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Reply
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406410/
https://www.ncbi.nlm.nih.gov/pubmed/36010190
http://dx.doi.org/10.3390/diagnostics12081837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406410/
https://www.ncbi.nlm.nih.gov/pubmed/36010190
http://dx.doi.org/10.3390/diagnostics12081837

Ejemplares similares